Results

1–10 of 58 results for RVO

The Reservoir Technique for Silicone Oil Placement: Intraocular Pressure Control and Long-Term Outcomes
Kathleen R Schildroth, MD
Annual Meeting Talks
2025
Ixoberogene Soroparvovec (Ixo-vec) Intravitreal Gene Therapy for Neovascular Age-Related Macular Degeneration (nAMD): Results From OPTIC and LUNA Trials
Mark R. Barakat, MD
Annual Meeting Talks
2025
Retinal Vein Occlusion with Good Baseline Visual Acuity: Immediate Treatment vs. Initial Observation
Ajay E Kuriyan, MD, MS
Updates from the Field
2026
Central Retinal Vein Occlusion
Tamara Zompa, MD
Martin Charles, MD
Retina Image Bank: Images of the Week
2026
Branch Retinal Vein Occlusion with Retinal Neovascularization
Retina Image Bank: Images of the Week
2025
Biosimilar Paradox: How Biosimilar Use Will Increase Patient and Healthcare Costs
Ravi Parikh, MD MPH
Annual Meeting Talks
2023
Retinal Arteriovenous Malformation
Korey Starkey
Retina Image Bank: Images of the Week
2025
Safety and Efficacy of Switching to Biosimilar Ranibizumab in Eyes Initially Treated With Reference Ranibizumab for nAMD, DME, or RVO
Nikhil K Bommakanti, MD
Annual Meeting Talks
2024
Safety and Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease: Phase 3 Results at 8 Years and 9 Years
Stephen R. Russell, MD
Annual Meeting Talks
2024
A Multicenter Post-Authorization Safety Study of Patients Treated With Voretigene Neparvovec-rzyl Gene Therapy in the United States: Interim Analysis at 3 Years
Aaron Nagiel, MD, PhD
Annual Meeting Talks
2024